Sie sind auf Seite 1von 11

Sample sent on: 27- feb- 13

Sample Approved on : 4-March- 13


printer test sent on
printer test approved on : 19 April, 13
Printer : Quad Graphics/Versailles.
CIP: To come from MH
Printer date:
Copy editing :
Indexing: Kathi Unger (US)
Proof reading:
Section No

Section name

Oncology

Boyiadzis STATUS REPORT

Chapter No

Chapter Name

PDF

1
2
3

Adrenocortical cancer
Anal Cancer
Biliary: Gallbladder Cancer and
Cholangiocarcinoma
Bladder Cancer
Brain cancer
BREAST CANCER
Carcinoma of Unknown Primacy
Cervical Cancer
Colorectal Cancer
Endometrial Cancer
Esophageal Cancer
Gastric Cancer
Gestational Trophoblastic Neoplasia
Head and Neck cancer
Hepatocellular Carcinoma
HIV-Related Malignancies
Leukemia, Acute Lymphoblastic
(ADULT)
LEUKEMIA, ACUTE MYELOGENOUS
Leukemia, chronic lymphocytic
Leukemia, Chronic Myelogeneous
Leukemia, hairy cell
Lung cancer
Lymphoma, Hodgkin
Lymphoma, Non Hodgkin
Melanoma
Mesothelioma

4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39

40
41

Count per Richard

20
26
38
8

20-Mar-13
20-Mar-13

25-Mar-13
25-Mar-13

25-Mar-13
25-Mar-13

29-Apr-13
29-Apr-13

25-Feb-13

2-Mar-13

29-Apr-13

25-Feb-13
25-Feb-13

2-Mar-13
2-Mar-13

46
34
25
105
8
30
45
28
13
14
9
37
51
110
33
11

18-Feb-13
23-Feb-13
23-Feb-13
23-Feb-13
23-Feb-13
17-Mar-13
4-Apr-13
10-Apr-13
4-Apr-13

20-Mar-13
20-Mar-13
20-Mar-13
20-Mar-13
20-Mar-13
20-Mar-13
22-Mar-13
20-Mar-13
22-Mar-13
22-Mar-13
22-Mar-13
23-Mar-13
23-Mar-13
22-Mar-13
12-Mar-13
23-Mar-13
21-Mar-13
22-Mar-13
14-Apr-13
14-Apr-13
10-Apr-13
15-Apr-13
10-Apr-13

25-Mar-13

29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13

14-Mar-13
14-Mar-13
16-Mar
18-Mar-13
16-Mar-13
19-Mar-13
19-Mar-13
16-Mar-13
20-Mar-13
20-Mar-13
20-Mar-13
21-Mar-13
19-Mar-13
19-Mar-13
28-Feb-13
22-Mar-13
18-Mar-13
19-Mar-13
5-Apr-13
5-Apr-13
8-Apr-13
14-Apr-13
8-Apr-13

25-Mar-13

7
17
91
11
18
25
10
25
22
12
59
4
14
22
14
15
9
7
21
27
54
16
6

25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
15-Apr-13
15-Apr-13
15-Apr-13
15-Apr-13
15-Apr-13

25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
25-Mar-13
16-Apr-13
16-Apr-13
16-Apr-13
16-Apr-13
16-Apr-13

29-Apr-13
29-Apr-13
29-Apr-13
29-Apr-13
29-Apr-13
29-Apr-13
29-Apr-13
29-Apr-13
29-Apr-13
29-Apr-13
29-Apr-13
29-Apr-13
29-Apr-13
29-Apr-13
29-Apr-13
29-Apr-13
29-Apr-13
20-May-13
20-May-13
20-May-13
20-May-13
20-May-13

8-Apr-13
10-Apr-13
10-Apr-13
12-Apr-13
10-Apr-13
11-Apr-13
11-Apr-13
11-Apr-13
15-Apr-13
10-Apr-13
10-Apr-13
11-Apr-13
11-Apr-13

10-Apr-13
14-Apr-13
15-Apr-13
14-Apr-13
15-Apr-13
15-Apr-13
15-Apr-13
15-Apr-13
16-Apr-13
15-Apr-13
15-Apr-13
15-Apr-13
15-Apr-13

20-May-13

29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13

17-Mar-13
23-Feb-13
4-Apr-13
12-Apr-13
23-Feb-13
17-Mar-13
4-Apr-13
4-Apr-13
15-Apr-13
23-Feb-13
17-Mar-13
22-Mar-13
23-Feb-13

16-Apr-13

41
15
47
12
5
19
36
81
14
4
12
6
8

14-Mar-13
14-Feb-13
1-Apr-13
9-Apr-13
14-Feb-13
14-Mar-13
3-Apr-13
3-Apr-13
12-Apr-13
14-Feb-13
14-Mar-13
14-Mar-13
14-Feb-13

15-Apr-13

83
23
94
19
10
43
54
152
27
10
25
7
15

15-Apr-13
15-Apr-13
15-Apr-13
15-Apr-13
15-Apr-13
15-Apr-13
15-Apr-13
15-Apr-13
15-Apr-13
15-Apr-13
15-Apr-13
15-Apr-13

16-Apr-13
16-Apr-13
16-Apr-13
16-Apr-13
16-Apr-13
16-Apr-13
16-Apr-13
17-Apr-13
16-Apr-13
16-Apr-13
16-Apr-13
16-Apr-13

20-May-13
20-May-13
20-May-13
20-May-13
20-May-13
20-May-13
20-May-13
20-May-13
20-May-13
20-May-13
20-May-13
20-May-13

8
26
5
7
15
31
5
7

15-Apr-13

16-Apr-13

20-May-13

14-Feb-13

23-Feb-13

11-Apr-13

14-Apr-13
15-Apr-13

16-Apr-13

20-May-13

7-May-13

10-Jun-13

12-Jul-13

7-May-13

10-Jun-13

12-Jul-13

7-May-13

10-Jun-13

12-Jul-13

7-May-13

10-Jun-13

12-Jul-13

7-May-13
7-May-13
7-May-13

10-Jun-13
10-Jun-13
10-Jun-13

12-Jul-13
12-Jul-13
12-Jul-13

159

65

30
27
2
83
32
44
19
3
21
18
27
1
7
15

328

328

143

29-Jan-13

43

43

32

29-Jan-13

Antineoplastic Drugs: Preventing


and Managing Extravasation

42

42

16

29-Jan-13

43

Indications for Growth Factors in the


Hematology-Oncology Setting

37

37

18

29-Jan-13

Indications for Biophosphonates in a


Hematology-Oncology Setting

Revised
proofs and
index (By TD)
proofs to

13-Mar-13
13-Mar-13

50

45
28
13
14
9

Proof corrections actually


received from mcgraw hill

2-Mar-13
2-Mar-13

105

159

Sent on

Proof Corrections due to Proof corrections actually


receive from editor
received from editor

25-Feb-13
25-Feb-13

6
11
5
16
19
5
10
9
10
25
4
14

Page Proofs
Due on

29-Jan-13
29-Jan-13
29-Jan-13

4
6

Inputs Receipt
CE Received
PR Received
CE Start Date
PR start date
Date
on
date

42

44

Supportive Care,
Drug Preparation,
Complications and
Screening

Multiple Myeloma
Pancreatic Endocrine Tumours
Ovarian Cancer
PANCREATIC CANCER
Pheochronocytoma
Prostate cancer
Renal Cell cancer
Sarcomas
Testicular Cancer
THYMIC MALIGNANCIES
Thyroid Cancer
Vaginal Cancer
Prophylaxis and Treatment of
Chemotherapy-Induced Nausea and
Vomiting (CINV)
Drug Preparation and
Administration
Guidelines for Chemotherapy
Dosage Adjustment

Doc

Typeset Pages
(excluding blank
pages)
10
8
11

17

11

14-Feb-13
27-Feb-13
27-Feb-13
26-Feb-13
26-Feb-13
1-Mar-13
6-Mar-13
5-Mar-13
8-Mar-13
1-Mar-13
5-Mar-13
14-Feb-13
14-Feb-13
14-Feb-13
14-Feb-13
14-Feb-13
14-Mar-13
16-Mar-13
9-Apr-13
29-Mar-13

23-Feb-13
2-Mar-13
2-Mar-13
2-Mar-13
2-Mar-13
2-Mar-13
10-Mar-13
10-Mar-13
10-Mar-13
2-Mar-13
10-Mar-13

14-Feb-13

2-Mar-13

11-Apr-13

15-Apr-13

14-Feb-13

10-Mar-13

20-Apr-13

1-May-13

14-Feb-13

10-Mar-13

22-Apr-13

1-May-13

14-Feb-13

10-Mar-13

23-Apr-13

1-May-13

22-Apr-13

23-Apr-13

30-Apr-13

2-May-13

12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13

12-Jul-13

6-May-13
6-May-13
6-May-13

12-Jul-13

29-Jan-13
6-May-13

45

Transfusion Therapy

30

30

24

29-Jan-13

46
47

Oncologic Emergencies
Fever and Neutropenia

53
12

53
12

27
9

29-Jan-13
29-Jan-13

19-Feb-13
19-Feb-13
19-Feb-13

10-Mar-13
10-Mar-13
10-Mar-13

23-Apr-13
24-Apr-13
30-Apr-13

1-May-13
1-May-13
2-May-13

6-May-13
6-May-13
6-May-13

Supportive Care,
Drug Preparation,
Complications and
Screening

48

49
50

51
52
53
54
55

Selected
Hematologic
Diseases

Catheter-Related Bloodstream
Infections: Management and
Prevention
Venous Catherer-Related
Thrombosis
Complications and Follow Up After
Hematopoietic Cell Transplantation
Radiation Complications
Cancer Pain: Assessment and
Management
Hospice Care and End of Life Issues

29-Jan-13
6-May-13

22-Apr-13
11

11

29-Jan-13

38

38

18

29-Jan-13

51

51
32

24
17

29-Jan-13
29-Jan-13

12

12

29-Jan-13

12

5
12

3
8

29-Jan-13
29-Jan-13

20

40
45
22
20

26
24
12
17

29-Jan-13
29-Jan-13
29-Jan-13
29-Jan-13

19

56
57
58
59
60

AUTOIMMUNE HEMOLYTIC ANEMIA

34

34

35

29-Jan-13

61

SICKLE CELL DISEASE: ACUTE


COMPLICATIONS
Aplastic Anemia
THROMBOTIC THROMBOCYTOPENIC
PURPURA / HEMOLYTIC UREMIC
SYNDROME (TTP/HUS)

30

30

26

29-Jan-13

15
10

15
10

8
8

29-Jan-13
29-Jan-13

IDIOPATHIC THROMBOCYTOPENIC
PURPURA
Hemochromatosis

20

20

14

29-Jan-13

11

11

29-Jan-13

Myeloproliferative Neoplasms
(MPN)
MYELODYSPLASTIC SYNDROMES
Total

81

81

40

29-Jan-13

34
1606

34
2633

17
1432

29-Jan-13

64
65
66
67

30-Apr-13

2-May-13
6-May-13

7-May-13

10-Jun-13

12-Jul-13

7-May-13

10-Jun-13

12-Jul-13

7-May-13
7-May-13

10-Jun-13
10-Jun-13

12-Jul-13
12-Jul-13

19-Feb-13

10-Mar-13

25-Apr-13

4-May-13

19-Feb-13
19-Feb-13

10-Mar-13
10-Mar-13

25-Apr-13
29-Apr-13

7-May-13
2-May-13

22-Apr-13

23-Apr-13

1-May-13

4-May-13

6-May-13

7-May-13

10-Jun-13

12-Jul-13

7-May-13
7-May-13

10-Jun-13
10-Jun-13

12-Jul-13
12-Jul-13

7-May-13
7-May-13
7-May-13
7-May-13

10-Jun-13
10-Jun-13
10-Jun-13
10-Jun-13

12-Jul-13
12-Jul-13
12-Jul-13
12-Jul-13

6-May-13

Cancer Screening
Genetics of Common Inherited
Cancer Syndromes
von Willebrand Disease
Hemophilia
The Hypercoagulable State
Heparin-Induced Thrombocytopenia

62
63

23-Apr-13

40
45
11

6-May-13

19-Feb-13
22-Apr-13

10-Mar-13
23-Apr-13

29-Apr-13
30-Apr-13

2-May-13
2-May-13

6-May-13

19-Feb-13
19-Feb-13
19-Feb-13
22-Apr-13

10-Mar-13
17-Mar-13
17-Mar-13
23-Apr-13

1-May-13
1-May-13
24-Apr-13
1-May-13

4-May-13
4-May-13
7-May-13
6-May-13

6-May-13

19-Feb-13

17-Mar-13

29-Apr-13

2-May-13

6-May-13

7-May-13

10-Jun-13

12-Jul-13

7-May-13

10-Jun-13

12-Jul-13

7-May-13
7-May-13

10-Jun-13
10-Jun-13

12-Jul-13
12-Jul-13

6-May-13

6-May-13
6-May-13
6-May-13

19-Feb-13

17-Mar-13

2-May-13

7-May-13

6-May-13

19-Feb-13
19-Feb-13

17-Mar-13
22-Mar-13

3-May-13
2-May-13

7-May-13
7-May-13

6-May-13

19-Feb-13

22-Mar-13

1-May-13 6_may-13

6-May-13
6-May-13

398

7-May-13

10-Jun-13

12-Jul-13

19-Feb-13

22-Mar-13

2-May-13

7-May-13

6-May-13

7-May-13

10-Jun-13

12-Jul-13

19-Feb-13

22-Mar-13

2-May-13

7-May-13

6-May-13

7-May-13

10-Jun-13

12-Jul-13

19-Feb-13
19-Feb-13

22-Mar-13
22-Mar-13

3-May-13
1-May-13

7-May-13
4-May-13

6-May-13

7-May-13
7-May-13

10-Jun-13
10-Jun-13

12-Jul-13
12-Jul-13

6-May-13

Revised pages actually


sent on

Final Printer Files due to


Final Printer Files to
McGraw-Hill
mcgraw-hill actually sent on

19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13

19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13

19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13

Remarks

19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13

19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13
19-Jul-13

EDITOR PREFERENCE SHEET


EDITOR NAME

Michael Boyiadzis

SCHEDULE SHARED ON

COMMENTS

7 feb, 13

thank you for your e-mail.


Looking forward working with
you.

MODE OF DELIVERY

SHIPPING ADDRESS

EMAIL ADDRESS

e.proofs

NA

boyiadzism@upmc.edu

Schedule for Boyiadzis Project


McGraw-Hill Production Manager: Richard Ruzycka
Project Development Editor: Harriet Lebowitz
Proofs Distribution: Editor + McGraw-Hill
Arts Proof Distribution: NA
Compositor - Thomson
XML: no
Printer: Quad Graphics/Versailles.
Printer Date: 19th July 2013

Milestone

Actual Dates

Material to Thomson
Cast Off /Estimate to McGraw-Hill HE

Original Scheduled
dates
29-Jan-13
20-Feb-13

Thomson to send Sample Chapter to McGraw-Hill HE


Thomson to send Printer Test
Copyediting completed
First Page proofs to Editor/MGH for Batch 1 - chapters 1 to 20
First Page proofs to Editor/MGH for Batch 2 -chapters 21 to 40
First Page proofs to Editor/MGH for Batch 3 -chapters 41 to 67
Return of First Page Proof corrections from Editors to TD
Marked revised proofs and index (By TD) proofs to McGraw-Hill
Final Print Files to McGraw-Hill HE

27-Feb-13
28-Mar-13
10-Apr-13
25-Mar-13
15-Apr-13
6-May-13
10-Jun-13
12-Jul-13
19-Jul-13

27-Feb-13
28-Mar-13

Editors will get 3 weeks to review each batch

Remarks

29-Jan-13
2-Mar-13

25-Mar-13
16-Apr-13
7-May-13

approved on
4-March

Copy editor

Richard Adin

Chapter
Due Date
Sample (chapter 17)
20-Feb
chapters 6, 18-21, 27, 30, 35,
38, 39

Actual Date
18-Feb
23-Feb

chapters 1-5, 7-11, 15, and 40

2-Mar

Chapter 1 to 20
Chapter 21 to 40
Chapter 41 to 67

9-Mar
30-Mar
10-Apr

Cast Off

31-Aug

PO

pages
496

496A
Additional PO
Invoice no
213017

Batch

Chapters
Pages
(chapters 6, 18-21, 27, 30, 35,
1 38, 39)

Amount
2000 $ 6,000.00
1000 $ 3,000.00
Amount
461 $

1,383.00

600 $

1,800.00

560 $

1,680.00

213025
213026
213030
213033

2 Chapters 1-5, 7-11, 15 and 40)


Chapters 12- 14, 16, 41-43, 453 47, 49-51, 53, 55
Chapter- 22, 26, 31, 36, 56,
4 57, 59, 60, and 61
5 Chapter 37, 62-67
6 Chapter 23, 25, 28, 32, 33
7 Chapter 24, 29 and 34

319
220
208
354

$
$
$
$

957.00
660.00
624.00
1,062.00

213035
213036

8 Chapter 44, 48, 52, 54 and 58


9 Chapter 15 and 16

86 $
49 $

258.00
147.00

52 $
2909 $

156.00
8,727.00

213019
213023

213038

10 Chapter 9 Additional pages

Proof reader- Heather


Chapter 17
chapter 1 to 20
Chapter 21 to 40
Chapter 41 to 67

Batch 1
Batch 2
Batch 1b
Batch 3

Invoice No.
1069
1076
1077
1088
Total

given to PR on 28 Feb
Due to PR
Back form PR
10-Mar
20-Mar
31-Mar
10-Apr
14-Apr
1-May

Pages
322
572
80
515
1489

Amount
$563
$1,001
$140
$901 includes 47 additonal pages for Chapter 9, 1
$2,605

al pages for Chapter 9, 15 and 16

Batch

Chapter No
24
25
28
29
32
33
34
44
48
52
54
58

Page No
110
33
23
94
43
54
152
17
8
32
5
22